Saturday, 7 March 2009

Drugs For Treating Aids May Prevent People From Catching Aids

In one of the most promising developments in more than 20 years, scientists claim that drugs used to control HIV/AIDS in patients may also be effective in preventing the disease in the first place.

The drugs in question are tenofovir (Viread) and emtricitabine, or FTC (Emtriva), sold in combination as Truvada by Gilead Sciences Inc. Gilead is the California company best known for inventing Tamiflu.

Previous research has been aimed at finding a vaccine against HIV/AIDS, with the intention of conditioning the immune system against the disease. But these drugs work differently. They simply keep the virus from reproducing, and have already been used successfuly by health care workers to prevent them from being infected by the virus carried by patients.

This approach to fighting HIV/AIDS has been tempting researchers for many years, but has only recently become feasible as preventative drugs have been developed that are safe for non-infected persons to take. Previous drugs had unreasonable effects for uninfected persons.

That situation changed when Tenofovir came on the market in 2001. Tenofovir is powerful and safe, and it only has to be taken once a day. It also does not interact with other medicines or birth control pills, and manifests less drug resistance than other AIDS medications.

Monkey studies show exciting results
A major study by the CDC (Centers for Disease Control and Prevention) in Atlanta, Georgia involved six macaques. The monkeys were given a combination of Tenofovir and FTC and then administered a deadly combination of monkey and human AIDS viruses. They were given the viruses in rectal doses to simulate contact between gay men.

Each was given 14 weekly exposures of the virus, and none of the monkeys became infected. In a control group which did not receive the drugs, all but one got the disease, normally after just two exposures.

The scientists then stopped giving the drugs to the test group to see if the prevention was only temporary. The results were equally impressive. None of the monkeys contracted the disease. "We're now four months following the animals with no drug, no virus. They're uninfected and healthy," reported a CDC researcher.

Now other research teams are pushing to have this drug combination tested on humans. A $29 million CDC study of drug users in Botswana will now be switched to this new drug combination.
Another study of 400 heterosexual women in Ghana by the Family Health Initiative, and funded by the Bill and Melinda Gates Foundation, is studying the effects of tenofovir alone.

But several other studies have failed to materialize because studies of this nature immediately raise suspicions that scientists are using local people as guinea pigs. The fear is that they will intentionally expose the test subjects to the virus.

The cost of tenofovir and Truvada also make testing difficult. In African countries condoms are now liberally donated by companies, aid groups, UN agencies, and western governments. While the drugs are relatively cheap, the cost remains an impediment.

Nevertheless researchers have been reinvigorated by the stunning results out of Atlanta, and new tests are going ahead in pockets of interest around the world.

CDC Recommends HIV Tests, Puts Less Stress on Condom Use

In a significant shift in strategy in the fight against HIV/AIDS, the Centers for Disease Control recently recommended that tests for HIV be extended to all patients entering hospitals and clinics in the U.S. The CDC also recommended that doctors begin offering routine voluntary HIV tests to patients between 13 and 64.

It is estimated that of the more than 1 million people in the U.S. with HIV and AIDS, about 25% are unaware they have HIV. The new strategy is aimed at discovering these cases before HIV develops into AIDS. It is also hoped these measures will curb the spread of the disease since these 250,000 people are carriers who unknowingly infect others.

This marks a departure from the previously followed strategy of testing only people in high risk categories.

This policy change will also involve a shift away from the promotion of abstinence and condom use to prevent the spread of the disease, towards more emphasis being placed on testing for HIV status and early treatment.

According to a spokesperson for the CDC, what explains this change in policy is that drugs now exist that can prevent the development of AIDS from HIV. Early detection can therefore result in early treatment. In the past early detection did not necessarily mean much since there was very little that could be done for someone infected with HIV.

It is also hoped that early detection will result in less transmission of the disease. A recent CDC survey found that sexually-active adults altered their sexual behavior patterns after they were diagnosed with HIV. They were less likely to engage in unprotected sexual activity, in many cases opting for a condom or for not engaging in sex at all.

Drug companies and makers of oral tests stand to benefit significantly from this change of emphasis. It is expected that tests which are now administered at hospitals and clinics will soon be available over the counter. People interested in testing themselves will be able to do it at home. This should result in a significant increase in sales of HIV testing kits.

There should also be a rise in HIV treatment drugs as hundreds of thousands of people learn they have HIV and begin treatment with anti-HIV drugs. Currently anti-HIV drugs account for about $6-billion in sales in the U.S. That number should increase dramatically if the new testing procedures prove to be effective.

Some argue that as in so many areas within the health industry, efforts aimed at prevention will be replaced by promises of a quick cure brought to us compliments of the incredibly influential and increasingly invasive drug companies.

What are AIDS and HIV?

AIDS stands for acquired immunodeficiency syndrome, a condition first reported in the United States in 1981, that has since become a major worldwide epidemic.

AIDS is caused by HIV (human immunodeficiency virus). By killing or damaging cells of the body's immune system, HIV progressively destroys the body's ability to fight infections and certain cancers. The term AIDS applies to the most advanced stages of HIV infection.

How is HIV spread?
There are several common ways that HIV can be passed from person to person, including:
  • Having unprotected sex with someone who is infected
  • Using needles or syringes that have been used by people who are infected
  • Receiving infected blood products or transplanted organs (Since 1985, the United States actively tests all donated blood for HIV; therefore, the risk of getting HIV in this way in the United States is now extremely low.)
  • Transmission from mother to child – An infected mother may pass the virus to her developing fetus during pregnancy, during birth, or through breastfeeding.

If you have a sexually transmitted disease, you may be at higher risk for getting infected with HIV during sex with an HIV-infected partner.

There is no evidence that HIV is spread by contact with saliva or through casual contact, such as shaking hands or hugging, or the sharing of food utensils, towels and bedding, swimming pools, telephones, or toilet seats. HIV is not spread by biting insects such as mosquitoes or bedbugs.

What is the treatment for HIV/AIDS?
Although when AIDS first appeared there were few treatments, researchers have now developed drugs that can help fight both HIV and the related infections and cancers that come with it. Treatment advances have improved the survival rates and decreased progression of HIV disease in developed countries like the United States, where antiretroviral drugs are available.
Additional treatment information is available from the National Institute of Allergy and Infection Diseases at NIH. The NIH is currently conducting many clinical trials related to HIV/AIDS to test treatments and therapies. These trials are sponsored and co-sponsored by various Institutes, including the NICHD.

The NICHD supports and conducts research related to HIV/AIDS in specific groups of people, including pregnant and non-pregnant women, infants and children, and adolescents and young adults. The information below applies to those groups.

How does HIV/AIDS affect women?
According to the Joint United Nations Programme on HIV/AIDS (UNAIDS), 19.2 million women are living with HIV/AIDS throughout the world. In many countries, the rate of HIV infection in women is rising faster than in any other group.

Worldwide, more than 80 percent of HIV infections are spread by heterosexual sex (vaginal intercourse); women are particularly at risk of contracting HIV through this type of contact. HIV is increasing most dramatically among African American and Hispanic women.

Although most of the signs and symptoms of HIV infection are similar in men and women, some are more specific to females. For example:
  • Vaginal yeast infections may be chronic, more severe, and difficult to treat in women with HIV infection than in women who are uninfected.
  • Pelvic inflammatory disease, an infection of the female reproductive organs, may also be more frequent and severe in women with HIV infection.
  • Human papillomavirus (HPV) infections, which cause genital warts, may occur more frequently in HIV-infected women, and can lead to pre-cancerous lesions of the cervix or cancer of the cervix.

The NICHD, along with other Institutes, supports studies to determine what aspects of HIV are specific to women and the best treatments for these symptoms.

How does HIV affect pregnant women and infants?
Women can give HIV to their babies during pregnancy, while giving birth, or through breastfeeding.

But, there are effective ways to prevent the spread of mother-to-infant transmission of HIV:

  • Taking anti-HIV drugs during pregnancy—either a drug called zidovudine or AZT alone or in combination with other drugs called highly active antiretroviral therapy (HAART)—a mother can significantly reduce the chances that her baby will get infected with HIV.
  • Delivering the baby by cesarean section, and doing so before the mother’s uterine membranes rupture naturally, reduces transmission that may occur during the birth process. Use of anti-HIV drugs during pregnancy and delivery, combined with a cesarean section in women with certain levels of HIV in their blood, can reduce the chance that the baby will be infected to less than 2 percent.
  • Avoidance of breastfeeding by an HIV-infected mother. HIV can be spread to babies through the breast milk of mothers infected with the virus. The American Academy of Pediatrics recommends that, in countries such as the United States, where infant formula is safe and is often available and affordable, HIV-infected women feed their infants commercially available formula instead of breastfeeding.
Approximately one-fourth to one-half of all untreated pregnant women infected with HIV will pass the infection to their babies. HIV infection of newborns is very rare in the United States because women are tested for HIV during pregnancy, and women with HIV infection receive anti-HIV drugs during pregnancy, cesarean delivery if their HIV blood levels are high, and are advised not to breastfeed their infants.

How does HIV affect children and adolescents?
It is estimated that approximately 10,000 children are living with HIV infection in the United States. In the United States, the number of infants born with HIV infection has dramatically decreased from about 2,000 a year to fewer than 200 a year due to identification of HIV infection in pregnant women and use of anti-HIV drugs during pregnancy, cesarean delivery, and avoidance of breastfeeding.

In contrast to the United States, mother-to-child transmission in developing countries remains a major problem; about 700,000 infants are newly infected with HIV each year because most women are not screened for HIV during pregnancy, anti-HIV drugs are not available, and safe alternatives to breastfeeding are not available.

Prior to 1985, when screening of the nation's blood supply for HIV began, some children as well as adults were infected through transfusions with blood or blood products contaminated with HIV, but this is now rare in the United States.

In contrast to the dramatic decrease in mother-to-child transmission of HIV infection, the number of cases of HIV infection in adolescents and young adults continues to increase in the United States. About one-third to one-half of new HIV infections in the United States are among adolescents and young adults.

Most HIV-infected adolescents and young adults are exposed to the virus through unprotected sex; some teens and young adults are also infected through injection drug use. In addition, an increasing number of children who were infected as infants are now surviving to adolescence.

AIDS-The Fear Epidemic

By any measure, AIDS is a frightening disease. It is physically devastating, incurable, and lethal. And it is spreading at a menacing pace. Fear and misconceptions about AIDS, however, have spread faster than the disease itself.

Federal health officials stress that the AIDS virus has spread almost exclusively by three routes: by sexual intercourse, through blood contact (contamination with or transfusion of infected blood or blood products), and from an infected pregnant woman to her fetus or newborn. The only other known instances in which the virus was transmitted, say officials, involved artificial insemination or organ transplants from infected donors.

But many people remain unconvinced. They fear that casual personal contact with an AIDS victim—a handshake, a sneeze, a drink from the same glass—might lead to infection. A child with AIDS attempting to attend school can throw a community into a frenzy. An AIDS patient returning to work may find coworkers deserting the job in protest.

In short, anxiety about AIDS has itself become epidemic. Part of the problem is that AIDS is a new disease—mysterious in its origin and initially baffling in its symptoms and cause. But the impression that scientists are groping amid a welter of unresolved questions is misleading. A vast amount of critical knowledge has already been gained about AIDS, and more is being learned all the time.

The epidemic first surfaced in the late 1970s, when rare cancers and uncommon infections began appearing in a number of gay (homosexual) men. Those illnesses were linked with a severe deficiency in the body's immune-defense system—a disorder initially called GRID, for Gay-Related Immune Deficiency. As late as mid-1981, gay men were still the only known victims in the United States, creating the impression that AIDS arose from something exclusive to that group.

By 1982, when the name became AIDS, for "acquired immune deficiency syndrome," the first currents of fear jolted the health-care community. The number of AIDS cases was rising geometrically, and the disease had appeared in two more groups—intravenous drug users and hemophiliacs. Not only did the pattern imply an infectious agent, but the disease was now affecting three of the principal groups vulnerable to hepatitis B infection—a viral illness that's also an occupational hazard among health workers.

AIDS would subsequently prove to be much less contagious than hepatitis B, partly because the number of hepatitis B virus particles in blood is up to a billion times greater than the number of AIDS virus particles. But no one knew that in 1982. Nor was it known that the AIDS virus doesn't penetrate intact skin or the linings of the respiratory and digestive tracts—and thus could not be transmitted by such things as a kiss on the lips, a cough, or food prepared by a person with AIDS.

With the number of cases doubling every six months, medical personnel on the front line became increasingly fearful for their own safety. That fear soon became evident to the public at large, helping to confirm impressions that a virulent plague was loose in the land. As public fear of the threat grew, scientific understanding of the disease advanced rapidly.

By mid-1984, three independent research teams in the United States and France had conclusively identified the virus that causes AIDS. Discovery of the virus—now designated "human immunodeficiency virus," or HIV—immediately opened new avenues of research into every aspect of the disease. Investigators have already deciphered the genetic code of the virus in search of ways to attack it. Others probing for clues to therapy have explored its crippling effect on the immune system.

For epidemiologists, who investigate the incidence, transmission, and patterns of disease, identification of the virus was the indispensable handle for a powerful new tool. It meant that a test could now be developed to detect individual exposure to the virus, information vital for deeper insight into the epidemic and its spread.
Elisa: Testing for Exposure to Aids
By 1985, a simple, inexpensive blood test for detecting exposure to the AIDS virus had been developed and approved for use. Called ELISA (for enzyme-linked immunosorbent assay), the test detects antibodies produced by white blood cells in response to the presence of the virus. Developed primarily to screen potential blood donors, ELISA has also served as a versatile research tool, greatly facilitating analysis of the epidemic's path.

Before ELISA, it was difficult to trace the spread of the virus. There was no practical way to detect it in people without symptoms, who represent the largest number of those infected. By mid-1988, about 65,000 cases of AIDS had been reported to the U.S. Centers for Disease Control (CDC). An estimated 325,000 people had AIDS-related complex (ARC), a term used to describe a condition that includes (in addition to laboratory evidence of immunodeficiency) swollen glands, recurrent fever, weight loss, or a combination of those symptoms. When persons with ARC develop any one of a number of opportunistic infections (or Kaposi's sarcoma), they are considered to have developed AIDS.

An estimated 1.6 million to 3.2 million additional people may be infected with the virus but have no symptoms of illness. Although their blood reveals antibodies to the virus—as determined by two consistently positive ELISA tests and a more sophisticated (and costly) confirming test called Western blot analysis—they may have no other laboratory or clinical signs of disease. Most public-health officials estimate that 30 to 50 percent of those people will ultimately develop full-blown AIDS.

With a practical means of detection in hand, researchers began probing areas previously obscure. For example, how fast was the virus spreading to the general population—or among intravenous-drug users, or gay men? Was it infecting family members who had no sexual contact with a victim in the home? Were some sexual practices riskier than others? Since 1985, a wealth of new information has become available to address those questions and others.

Some of the findings are uncompromisingly bleak. Among high-risk groups, the AIDS virus is cutting a widening swath of infection, particularly in areas that have already borne the brunt of the epidemic, such as metropolitan New York and San Francisco. The infection is also spreading among young adults in inner-city minority groups, especially black and Hispanic intravenous-drug users and their sexual partners. One analysis of blood tests administered to some 300,000 military recruits found the rate of infection in blacks to be four times that in whites.

Federal health officials have predicted that the cumulative total of AIDS cases could reach 270,000 by 1991, with 179,000 deaths. Most of those will be people who are already infected with the virus, the officials said.

The grim projections of unfolding tragedy have overshadowed all other emerging information about the epidemic. But there has been another side to the news. An increasing number of epidemiological studies now point to an unmistakable conclusion: The reassurances from health officials about casual contact with AIDS patients are well founded. As CDC director James O. Mason, M.D., put it, "This is a very difficult disease to catch."

Transmission appears to require not only direct insertion of the virus into the bloodstream but also a substantial dose of the virus—much more than could be transmitted by casual contact. Indeed, a consistent pattern in people who become infected is frequent or severe exposure to the virus.

Even in sexual intercourse—the primary route of infection—the virus does not appear to spread easily. Like most sexually transmitted diseases, AIDS is strongly associated with a highly active sex life and multiple partners.

Homosexual Transmission
Among gay and bisexual men, the disease first appeared in those with extremely large numbers of sexual partners—a lifetime average of over 1000 partners, according to one early epidemiologic study. It's not known whether multiple sexual contacts raise the risk simply by raising the odds that a person will encounter the AIDS virus once, or by some process in which the body's defenses are worn down (perhaps through exposure to other sexually transmitted diseases), or both. All that's known for sure is that having a large number of sexual partners raises the risk.

Now that the virus is more prevalent—and the odds of catching it (among people at risk) are higher—the average number of sexual partners reported by people who contract the disease would be far less than 1000. No precise numbers, however, are available.

A key factor in the rapid spread of the virus among gay and bisexual men is the practice of anal intercourse, probably because the surface membranes and blood vessels of the anal canal are vulnerable to small fissures or tears during intercourse. Such tears may allow virus carried in semen to gain entry into the bloodstream of the receiving partner. The risk of viral transmission is especially high for the partner accepting penetration (receptive anal intercourse). In one six-month study examining transmission of the virus in gay men, a University of Pittsburgh research team found receptive anal intercourse to be the major risk factor in infection. At the outset, none of the men showed any evidence of AIDS virus in their blood. After six months, however, antibodies to the virus were found in a number of the subjects, especially among men who had had two or more sexual partners. In that group, men engaging in receptive anal intercourse had 16 times the infection rate as those having no anal intercourse.

As yet, there's no scientific evidence that sexual practices other than anal-related sex lead to AIDS-virus transmission in gay men. However, only a few large studies have compared the effects of different sexual practices.

One such study was conducted by University of California researchers over a two-year period for the San Francisco Men's Health Study. The California investigators examined infection rates among some 800 gay or bisexual men with different sexual histories. No difference in infection rates was found between those who engaged solely in oral-genital sex and those who had no sexual partners at all.

The California researchers concluded that the risk of AIDS-virus transmission by oral-genital contact was minimal. But they cautioned—as did the Pittsburgh group—that their findings did not prove that sexual activity other than anal intercourse posed no risk among gay men. They pointed out that their results were based on a relatively small number of observations and could not completely exclude the possibility of transmission by oral-genital sex.

Indeed, caution has been the watchword among public-health officials offering preventive advice. Since more than 90 percent of AIDS cases have occurred in gay or bisexual men and intravenous-drug users, the message to those high-risk groups has stressed avoiding any possible risk. One drawback of that approach, however, is that it makes AIDS appear easier to catch than it actually is. Some public-health workers, for example, warn against deep kissing involving exchange of saliva. But there's no evidence that the virus is transmitted that way.

Heterosexual Transmission
In contrast to oral sex or deep kissing, vaginal intercourse is clearly an important route of infection. The AIDS virus can be spread by either a man or a woman during intercourse.

On a relative scale, vaginal intercourse appears to be less effective in spreading the virus than anal intercourse, and less contagious from female to male than the reverse. As yet, the risk of transmission in a single act of vaginal intercourse is unknown. But current evidence suggests that frequent or long-term sexual exposure with an infected partner or partners is an important factor in transmission.

As of mid-1988, about 4 percent of newly diagnosed AIDS cases in the U.S. can be traced to heterosexual transmission. A large number of the victims are spouses or long-term sexual partners of AIDS patients or other high-risk individuals, particularly intravenous-drug users. Another large segment includes immigrants from Haiti and central Africa, where the virus spreads mainly by heterosexual intercourse.

Some confusion initially surrounded the status of Haitians, who were once listed as a separate risk group for AIDS. Epidemiologists have since found that the infection rate is not high among Haitians who are longterm U.S. residents. It's high, though, among recent immigrants with a history of venereal disease or sexual contact with prostitutes. In both Haiti and central Africa, infected prostitutes are an important factor in the spread of the virus among heterosexuals.

Reports from central Africa also show that AIDS is concentrated among urban people who are very sexually active. The average AIDS patient had more than 30 sex partners a year, including frequent contacts with prostitutes.

Overall, heterosexual spread of the infection often involves multiple sexual exposures to the virus. Even under these circumstances, however, infection is far from automatic. In a number of studies based on antibody tests, 50 to 65 percent of the regular heterosexual partners of patients with AIDS or advanced AIDS-related illness have shown no evidence of the virus in their blood. And among the wives or regular sex partners of hemophiliacs with AIDS, 90 to 95 percent were not infected.

The fact that such prolonged sexual exposure often fails to cause infection certainly argues against fears that a bathtub, toilet seat, or the air around an AIDS patient could pose a threat.

Public-health officials generally recommend using condoms during anal or vaginal intercourse and oral-genital sex to reduce the risk of AIDS-virus transmission. CDC investigators, after evaluating many studies from around the world, concluded that barrier contraceptives—condoms, spermicides, and diaphragms used with spermicides—are effective in reducing the risk of sexually transmitted diseases, including AIDS. Lubricants, if used, should be water-based; petroleum products can damage latex.

One lab experiment demonstrated that the AIDS virus can't penetrate an intact latex condom. Another showed that a common spermicide, nonoxynol-9, inactivates the virus and kills the white blood cells that carry it. (Nonoxynol-9 is the spermicide in many contraceptive jellies and foams, and the active ingredient in the contraceptive sponge Today.)

Blood-to-Blood Contact
The rapid spread of the AIDS virus among intravenous-drug users fosters the impression that the virus is highly infectious. Actually, some common practices among addicts who use needles are what make them especially vulnerable. And while there is some evidence that gay people have modified their risk behavior, drug abusers have not.

In addition to the frequency of injections—at least daily in many users—intravenous-drug addicts often share their needles and syringes. Indiscriminate sharing of injection paraphernalia has become common at drug "shooting galleries," where addicts go to rent or share equipment. "Often, the same needle will be used for up to 50 injections until it is no longer usable," reports Peter Selwyn, M.D., medical director of a drug-treatment program for addicts at Montefiore Medical Center in the Bronx, New York.

The risk of contamination is multiplied by another practice—drawing blood back into the syringe so that any remaining drug can be flushed out of the syringe and into the vein. If an addict is infected with the virus, a significant dose of it may be transmitted to the next sharer. In short, intravenous-drug use is an extremely effective way of acquiring a blood-borne disease—even one as difficult to contract as AIDS.

Some people have proposed that government agencies should make sterile needles and syringes available to intravenous-drug users, either free or at cost. Facing the threat of an AIDS epidemic in 1984, the Amsterdam (Netherlands) Municipal Health Service adopted such a plan. It appears to be working. The number of addicts using intravenous drugs has not increased, and more addicts than ever have been motivated to enter treatment for their addiction. Similar programs have since been initiated in Sweden, Great Britain, France, Italy, and Australia.

Such proposals in the United States have generally met with strong opposition. In 1988, the first attempt at a free-needle program was made in Portland, Oregon; it stalled when insurance coverage was refused. New York City began a similar program the same year. Yet even advocates of the idea recognize it as a stopgap measure. They emphasize the need for more drug-treatment centers and a multifaceted approach to the problem. But an epidemic often demands swift action. Cheap, clean needles and syringes would at least reach the inner-city battleground where AIDS has hit hardest and where the real war on drugs is being fought—and lost.

The experience of health-care workers, meanwhile, provides a striking contrast to the epidemic among intravenous-drug users. Seven separate studies in the United States and England have examined the outcome of needle-stick and other exposures among health workers caring for AIDS patients. Approximately 1500 people—nurses, physicians, medical students, technicians, and laboratory workers—were studied to determine whether their exposures had resulted in infection. Most of the exposures were needle-stick injuries from instruments that had just been used for an AIDS patient. The rest were direct exposures of a mucous membrane, such as a splash of infected blood into the eye or nostrils.

Despite the large number of exposures, only five of the 1500 workers developed AIDS-virus antibodies in their blood. Those five had experienced a severe exposure, such as a deep injection wound or a puncture from a grossly contaminated large-bore biopsy needle. None of the workers who had direct exposure of mucous membrane to blood or other body fluid developed infection.
Hemophilia, a genetic disorder marked by the absence of an important clotting factor, results in repeated bleeds, often into joints. Transfusions of blood products can correct the bleeding temporarily. Before routine screening of blood and blood products for the AIDS virus was initiated in 1985, many hemophiliacs became infected. Since then, the risk has been virtually eliminated.

Casual Contact: How Aids Is Not Transmitted
Detection of the AIDS virus in saliva in 1984, and subsequently in tears, sparked immediate public concern. But further research has shown that the virus is rarely present in either. When it is, the quantity is minute—probably too low, say most public-health experts, to play a role in infection. Nevertheless, as a precaution, they still warn against deep kissing with an infected person and advise special procedures for eye-care and dental personnel, who are constantly exposed to tears or saliva.

No such precautions apply to contact with drinking glasses, eating utensils, eyeglasses, and the like. All evidence shows that the risk from such items is nonexistent. The same is true for a typical friendly kiss.

Some parents of young schoolchildren also fear that a bite from an infected classmate might transmit the virus. Here again, the concern is unwarranted, experts at the CDC say. The amount of virus in saliva—if any—is considered too minuscule to cause infection, especially in a single instance of biting.

There is no evidence that the virus can be transmitted by food or by any variety of insect. Nurses who have administered mouth-to-mouth resuscitation to AIDS patients have not become infected. Nor have children attending school with hemophiliac classmates who were infected. But possibly the strongest evidence that the virus presents no threat in casual contact comes from studies in families.

If AIDS could spread through casual contact, a patient's home would be a likely breeding ground of infection. The close personal environment of a family household would offer ample opportunities for spreading the virus.

It hasn't happened, however. Studies in U.S. households and among families in Europe, Haiti, and central Africa have all produced the same result. No instance of transmission has occurred among anyone who wasn't the sexual partner or newborn infant of an infected person.

The most comprehensive study is an ongoing, long-term investigation being conducted jointly by the CDC, Montefiore, North Central Bronx Hospital, and Albert Einstein College of Medicine. In 1986, the research group reported its evaluation of 101 people living in households with 39 AIDS patients. None of the 101 household members were sexual partners of the patients, but all lived in close personal contact with the infected person for periods ranging from three months to four years.

"Most of the families in this study were poor and lived in crowded conditions," the researchers reported. "A high percentage of household members assisted the patient with bathing, dressing, and eating." There was close personal interaction, and substantial sharing of household facilities and items likely to be soiled with body secretions. Some of the household members used the same razors and toothbrushes as the patient. Many shared the same combs, eating utensils, plates, and drinking glasses. More than 90 percent used the same toilet, bath, and kitchen facilities as the patient, and 37 percent shared the same bed. Most also engaged in affectionate behavior with the patient, including hugging and kissing on the cheek or lips.

Except for one child infected at birth, all of the 101 households examined were found to be free of any sign of AIDS virus in their blood. The researchers concluded that transmission of the virus through ordinary personal contact "appears to be minimal or nonexistent in the household setting."

The research group has continued its investigation since that report. As of the spring of 1988, it had completed examinations of more than 200 family members in more than 75 households, including reexaminations of the original subjects. None (except the one child) showed evidence of infection.

Similar findings were recently reported from central Africa. A research group in Kinshasa, Zaire, investigated whether the same results reported among household members in Europe and North America apply under conditions common in the developing world.

"Unlike living conditions in the United States and Europe," said the report, "living conditions in households in Kinshasa are more likely to include environmental factors favoring person-to-person transmission of infectious agents." Such conditions, the report said, included "crowding, lack of modern sanitary systems, and substantial numbers of mosquitoes and other arthropods."
The study, which evaluated 204 household members of AIDS patients, found no evidence that the virus was spread by ordinary personal contact. The researchers concluded that transmission by nonsexual personal contact "appears to be very rare, if it occurs at all."

The Kinshasa group also suggested what many American and European epidemiologists have come to realize, with profound relief: Since the AIDS virus isn't spreading in the home, transmission by casual contact in workplaces, schools, or similar settings will probably never occur.

AIDS/HIV Information

AIDS is an acronym for Acquired Immunodeficiency Syndrome it causes a destruction of the immune system. It is the most advanced stage of the HIV virus (HIV stands for Human Immunodeficiency Virus). AIDS is defined by the Centers for Disease Control and Prevention (CDC) as the presence of a positive HIV antibody test and one or more of the illnesses known as opportunistic infections.

The HIV virus, type 1 or 2 is widely known to be the cause of AIDS. HIV breaks down and attacks your T cells so your body is unable to defend itself against different infections. The HIV virus also attacks your peripheral nervous system, this causes nerve and muscle pain, especially in the feet, legs, and hands.

HIV is spread through direct contact with semen or blood of an individual that is infected. This can be transferred in many ways the most common is unprotected sexual intercourse. Other means of infection are infected blood transfusions, mother to infant (at time of birth, or through breast milk), sharing needles with an infected person, and rarely a healthcare worker that gets pricked with an infected needle.

Often people who are infected with HIV have few symptoms and in some cases there are none. Other times, symptoms of HIV are confused with other illnesses such as the flu. This may be severe, with swollen glands in the neck and armpits, tiredness, fever and night sweats. This is where as much as 9 out of 10 of the infected individuals will develop AIDS. At this point the person may feel completely healthy and not even know that he/she has the virus. The next stage begins when the immune system starts to break down and the virus becomes more aggressive in damaging white cells. Several glands in the neck and armpits may swell and stay swollen for an extended period of time without any explanation. As this disease progresses boils or warts may spread over the body. They may also feel tremendously tired, night sweats, high fevers, chronic diarrhea, and they may lose a considerable amount of their body weight. Most cases have shown thrush as a symptom as well. At this point the person is in the final stages of HIV--AIDS. Severe chest infections with high fever are common and survival rate is above 70% but decrease with each recurrence.

A person is diagnosed with AIDS when he/she has one or more positive HIV screening and the presence of an AIDS defining condition. Some of the common conditions include but are not limited to: Meningitis, Encephalitis, Dementia, Pneumonia, Kaposi sarcoma, and Lymphoma. There is also a blood test called an Immune Profile that can be done. This test is used to measure the loss of immunity and help decide on the best treatment. There is a test that is rarely used due to its high cost, it is known as a Viral Load: This test detects the virus itself, and also measures the amount of HIV in the blood. It shows how quickly the HIV infection is likely to advance. A high viral load suggests that the person may progress rapidly to AIDS.

Although there is no cure for AIDS there are medical treatments that aide in prolonging, and maintaining the best quality of life possible. These include two nucleoside inhibitors, lamivudine and zidovudine. Actual treatment plans will vary with each patient, along with the physical aspect of this disease. The psychological side has to be addressed in order for a treatment plan to be effective.

The easiest way to escape contracting this disease is to avoid the risk factors that you are in control of. Such as: unprotected sex, not sharing a needle, and if you are in the healthcare field be sure to use all precautions necessary to avoid an accidental prick from a possible infected needle (remember that in this diseases early stages it is common for the person not to even know they are infected). Today AIDS is the fifth leading cause of death among all adults aged 25 to 44 in the United States. Among African-Americans in the 25 to 44 age group, AIDS is the leading cause of death for men and the second leading cause of death for women. Our society needs to become aware that by not protecting ourselves we are killing ourselves and that this has to stop.

Anatomy of the Human Brain


The image on the left is a side view of the outside of the brain, showing the major lobes (frontal, parietal, temporal and occipital) and the brain stem structures (pons, medulla oblongata and cerebellum).

The image on the right is a side view showing the location of the limbic system inside the brain. The limbic system consists of a number of structures, including the fornix, hippocampus, cingulate gyrus, amygdala, the parahippocampal gyrus and parts of the thalamus. The hippocampus is one of the first areas affected by Alzheimer's disease. As the disease progresses, damage extends throughout the lobes.

Glossary of Terms for an Anatomy of the Brain

Amygdala – limbic structure involved in many brain functions, including emotion, learning and memory. It is part of a system that processes "reflexive" emotions like fear and anxiety.

Cerebellum – governs movement.

Cingulate gyrus – plays a role in processing conscious emotional experience.

Fornix – an arch-like structure that connects the hippocampus to other parts of the limbic system.

Frontal lobe – helps control skilled muscle movements, mood, planning for the future, setting goals and judging priorities.

Hippocampus – plays a significant role in the formation of long-term memories.

Medulla oblongata – contains centers for the control of vital processes such as heart rate, respiration, blood pressure, and swallowing.

Limbic system – a group of interconnected structures that mediate emotions, learning and memory.

Occipital lobe – helps process visual information.

Parahippocampal gyrus – an important connecting pathway of the limbic system.

Parietal lobe
– receives and processes information about temperature, taste, touch, and movement coming from the rest of the body. Reading and arithmetic are also processed in this region.

Pons – contains centers for the control of vital processes, including respiration and cardiovascular functions. It also is involved in the coordination of eye movements and balance.

Temporal lobe – processes hearing, memory and language functions.

Thalamus – a major relay station between the senses and the cortex (the outer layer of the brain consisting of the parietal, occipital, frontal and temporal lobes).

Types of Brain Tumors

There are many different types of brain tumors. They are usually categorized by the type of cell where the tumor begins, or they are also categorized by the area of the brain where they occur. The most common types of brain tumors include the following:

Gliomas
The most common type of primary brain tumor is a glioma. Gliomas begin from glial cells, which are the supportive tissue of the brain. There are several types of gliomas, categorized by where they are found, and the type of cells that originated the tumor. The following are the different types of gliomas:
  • Astrocytomas
    Astrocytomas are glial cell tumors that are derived from connective tissue cells called astrocytes. These cells can be found anywhere in the brain or spinal cord. Astrocytomas are the most common type of childhood brain tumor, and the most common type of primary brain tumor in adults. Astrocytomas are generally subdivided into high-grade or low-grade tumors. High-grade astrocytomas are the most malignant of all brain tumors. Astrocytomas are further classified for presenting signs, symptoms, treatment, and prognosis, based on the location of the tumor. The most common location of these tumors in children is in the cerebellum, where they are called cerebellar astrocytomas. These persons usually have symptoms of increased intracranial pressure, headache, and vomiting. There can also be problems with walking and coordination, as well as double vision. In adults, astrocytomas are more common in the cerebral hemispheres (cerebrum), where they commonly cause increased intracranial pressure (ICP), seizures, or changes in behavior.

  • Brain stem gliomas
    Brain stem gliomas are tumors found in the brain stem. Most brain stem tumors cannot be surgically removed because of the remote location and delicate and complex function this area controls. Brain stem gliomas occur almost exclusively in children; the group most often affected is the school-age child. The child usually does not have increased intracranial pressure (ICP), but may have problems with double vision, movement of the face or one side of the body, or difficulty with walking and coordination.

  • Ependymomas
    Ependymomas are also glial cell tumors. They usually develop in the lining of the ventricles or in the spinal cord. The most common place they are found in children is near the cerebellum. The tumor often blocks the flow of the CSF (cerebral spinal fluid, which bathes the brain and spinal cord), causing increased intracranial pressure. This type of tumor mostly occurs in children younger than 10 years of age. Ependymomas can be slow growing, compared to other brain tumors, but may recur after treatment is completed. Recurrence of ependymomas results in a more invasive tumor with more resistance to treatment.

  • Optic nerve gliomas
    Optic nerve gliomas are found in or around the nerves that send messages from the eyes to the brain. They are frequently found in persons who have neurofibromatosis, a condition a child is born with that makes him/her more likely to develop tumors in the brain. Persons usually experience loss of vision, as well as hormone problems, since these tumors are usually located at the base of the brain where hormonal control is located. These are typically difficult to treat due to the surrounding sensitive brain structures.

  • Oligodendrogliomas
    This type of tumor also arises from the supporting cells of the brain. They are found commonly in the cerebral hemispheres (cerebrum). Seizures are a very common symptom of these tumors, as well as headache, weakness, or changes in behavior or sleepiness. This tumor is more common in persons in their 40s and 50s. These tumors have a better prognosis than most other gliomas, but they can become more malignant with time.

Metastatic tumors
In adults, metastatic brain tumors are the most common type of brain tumors. These are tumors that begin to grow in another part of the body, then spread to the brain through the bloodstream. When the tumors spread to the brain, they commonly go to the part of the brain called the cerebral hemispheres, or to the cerebellum. Often, a patient may have multiple metastatic tumors in several different areas of the brain. Lung, breast, and colon cancers frequently travel to the brain, as do certain skin cancers. Metastatic brain tumors may be quite aggressive and may return even after surgery, radiation therapy, and chemotherapy.

Meningiomas
Meningiomas are usually benign tumors that come from the meninges or dura, which is the tough outer covering of the brain just under the skull. This type of tumor accounts for about 15 percent of brain tumors. They are slow growing and may exist for years before being detected. Meningiomas are most common in patients in their 40s and 50s. They are commonly found in the cerebral hemispheres just under the skull. They usually are separate from the brain and can sometimes be removed entirely during surgery. They can, however, recur after surgery and certain types can be malignant.

Schwannomas
Schwannomas are benign tumors, similar to meningiomas. They arise from the supporting cells of the nerves leaving the brain, and are most common on the nerves that control hearing and balance. When schwannomas involve these nerves, they are called vestibular schwannomas or acoustic neuromas. Commonly, they present with loss of hearing, and occasionally loss of balance, or problems with weakness on one side of the face. Surgery can be difficult because of the area of the brain in which they occur, and the vital structures around the tumor. Occasionally, radiation (or a combination of surgery and radiation) is used to treat these tumors.

Pituitary tumors
The pituitary gland is a gland located at the base of the brain. It produces hormones that control many other glands in the body. These glands include the thyroid gland, the adrenal glands, the ovaries and testes, as well as milk production by pregnant women, and fluid balance by the kidney. Tumors that occur in or around the area of the pituitary gland can affect the functioning of the gland, or overproduce hormones that are sent to the other glands. This can lead to problems with thyroid functioning, impotence, milk production from the breasts, irregular menstrual periods, or problems regulating the fluid balance in the body. In addition, due to the closeness of the pituitary to the nerves to the eyes, patients may have decreased vision. Tumors in the pituitary are frequently benign, and total removal makes the tumors less likely to recur. Since the pituitary is at the base of the skull, approaches for removal of a pituitary tumor may involve entry through the nose or the upper gum. Certain types of tumors may be treated with medication, which, in some cases, can shrink the tumor or stop the growth of the tumor.

Primitive neuroectodermal tumors (PNET)
PNET can occur anywhere in the brain, although the most common place is in the back of the brain near the cerebellum. When they occur here, they are called medulloblastomas. The symptoms depend on their location in the brain, but typically the patient experiences increased intracranial pressure. These tumors are fast growing and often malignant, with occasional spreading throughout the brain or spinal cord.

Medulloblastomas
Medulloblastomas are one type of PNET that are found near the midline of the cerebellum. This tumor is rapidly growing and often blocks drainage of the CSF (cerebral spinal fluid, which bathes the brain and spinal cord), causing symptoms associated with increased ICP. Medulloblastoma cells can spread (metastasize) to other areas of the central nervous system, especially around the spinal cord. A combination of surgery, radiation, and chemotherapy is usually necessary to control these tumors.

Craniopharyngioma
Craniopharyngioma are benign tumors that occur at the base of the brain near the nerves from the eyes to the brain, and the hormone centers. Most persons with this type of brain tumor develop symptoms before the age of 20. Symptoms include headaches, as well as problems with vision. Hormonal imbalances are common, including poor growth and short stature. Symptoms of increased intracranial pressure may also be seen. Although these tumors are benign, they are hard to remove due to the sensitive brain structures that surround them.

Pineal region tumors
Many different tumors can arise near the pineal gland, a gland that helps control sleep and wake cycles. Gliomas are common in this region, as are pineal blastomas. In addition, germ cell tumors, another form of malignant tumor, can be found in this area. Tumors in this region are more common in children than adults, and make up 3 to 8 percent of pediatric brain tumors. Benign pineal gland cysts are also seen in this location, which makes the diagnosis difficult between what is malignant and what is benign. Biopsy or removal of the tumor is frequently necessary to tell the different types of tumors apart. Persons with tumors in this region frequently experience headaches or symptoms of increased intracranial pressure. Treatment depends on the tumor type and size.